INVO Fertility, Inc. (IVF) vs Jupiter Neurosciences, Inc. (JUNS)
A side-by-side comparison of INVO Fertility, Inc. and Jupiter Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IVF
INVO Fertility, Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 10:38 AM EDT
JUNS
Jupiter Neurosciences, Inc.
$2.43HealthcareDelayed quote: Oct 6, 2026, 10:36 AM EDT
Total return — IVF vs JUNS
growth of $100 · dividends reinvested · last 2yIVF -99.9% (-97.5%/yr)JUNS -99.4% (-92.3%/yr)JUNS compounded faster over this window
Log scale — wide-divergence pair
IVF JUNS
IVF vs JUNS: by the numbers
- •IVF is the larger company ($1M vs $1M market cap).
- •Both run net losses; IVF's is the smaller (-70.18% vs -14220.12% net margin).
- •IVF grew revenue faster over the past five years (39.51% vs -47.77% CAGR).
Metrics side by side
Valuation
| Metric | IVF | JUNS |
|---|---|---|
| P/S ratio | 0.19 | 18.21 |
| P/B ratio | 0.09 | N/A |
Profitability
| Metric | IVF | JUNS |
|---|---|---|
| Gross margin | 33.34% | 88.34% |
| Operating margin | -78.72% | -40873.19% |
| Net margin | -70.18% | -14220.12% |
| ROE | -32.05% | N/A |
| ROIC | -28.43% | -709.40% |
Growth (annualized)
| Metric | IVF | JUNS |
|---|---|---|
| Revenue CAGR (5Y) | 39.51% | -47.77% |
| Total return CAGR (5Y) | -90.41% | N/A |
Frequently asked
- Which has grown faster, IVF or JUNS?
- Over the past five years, IVF grew revenue faster — IVF at a 39.51% CAGR versus JUNS at -47.77%.
Go deeper
Dig into the metrics
INVO Fertility ROEJupiter Neurosciences ROEINVO Fertility operating marginJupiter Neurosciences operating marginINVO Fertility revenue growthJupiter Neurosciences revenue growthINVO Fertility free cash flowJupiter Neurosciences free cash flow
INVO Fertility & Jupiter Neurosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.